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OBJECTIVES: In light of the increasing number of high-tech industry workers and the differences in their working
conditions compared to those of the general population, the health status of these workers merits serious attention.
This study aimed to explore the prevalence of metabolic syndrome and its correlates among Taiwanese high-tech
industry workers.
METHODS: This cross-sectional study included 4,666 workers who participated in labor health examinations at a
hospital in southern Taiwan in 2008. Participants with metabolic syndrome were defined using the criteria proposed
by the Taiwan National Department of Health in 2007. Factors associated with metabolic syndrome were
determined using multiple logistic regression analysis.
RESULTS: The overall prevalence of metabolic syndrome was 8.2%, and the prevalence was higher in men than in
women (14.0% vs. 2.3%, p,0.01). Male gender, advanced age, elevated white blood count, and elevated levels of
blood biochemistry markers, such as alanine aminotransferase and uric acid, can independently predict metabolic
syndrome.
CONCLUSIONS: The prevalence of metabolic syndrome among high-tech industry workers is lower than in the
general population. Our study’s findings may facilitate early health assessments and the provision of proper
workplace health promotion programs to reduce the risks faced by high-risk workers.
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INTRODUCTION
As a result of economic growth and associated socio-
demographic shifts, changes in lifestyle and diet have led to
an elevated risk with respect to chronic diseases, especially
cardiovascular disease. According to the World Health
Organization (WHO), cardiovascular disease is the leading
cause of death worldwide, claiming 17.5 million victims
yearly.1 This high mortality rate creates an enormous
financial burden. In the European Union, the yearly direct
and indirect economic cost of cardiovascular disease is as
high as 169 billion EUR.2 In contrast, after reviewing the top
ten causes of mortality in Taiwan, we found that chronic
diseases had replaced infectious diseases as the main cause
of death. For example, according to statistics reports from
the Taiwan National Department of Health in 2008,3 the
mortality attributed to metabolic abnormalities (29.5%),
including cerebrovascular disease, heart disease, diabetes
mellitus, hypertension, and pyelonephritis, had surpassed
cancer mortality (27.3%), revealing that metabolic abnorm-
alities have become a major health challenge.
Given its threat to the well-being of humans, a syndrome
related to insulin resistance abnormalities was first pro-
posed by Reaven in 1988.4 Subsequently, in 1998, the WHO
introduced the first internationally recognized term for
metabolic abnormalities, metabolic syndrome (MS), which is
characterized by a core set of disorders, including glucose
intolerance, central obesity, dyslipidemia, and hypertension
co-occurring within an individual.5 Although there is still
some debate as to the precise definition of MS, its
prevalence around the world has been estimated at
approximately 7% to 58% according to the Adult
Treatment Panel III definition, and these figures were still
rising when the criteria were specified by the WHO.6
Recently, investigators have reported on the challenge
that MS poses for human health. For example, MS is not
only an indication of the likelihood of developing coronary
heart disease or type II diabetes but is also associated with a
threefold greater risk of cardiovascular death, as compared
to those without the disorder.5 Additionally, MS is related to
cerebral atrophy, which may trigger depression and
cognitive impairment.7,8 Most recently, studies on the
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correlation between malignancy and MS have shown that
patients with MS have a 1.6-fold higher risk of death from
cancer than those without MS.9 Therefore, clarifying the
factors related to MS and to identify high-risk cases early
may be of utmost importance for public health.
Workers are an important part of any institution. Since
the promulgation of the Ottawa Charter for Health
Promotion by the WHO in 1986, global support for work-
place health promotion has encouraged employers to hold
health promotion activities to ensure employee health.10
With increasing competition in the global market and the
rapid development of technology, all countries (including
Taiwan) seek to foster growth in high-tech industries.
Facilitated by support from the government, high-tech
products comprised 71.2% of all exports from Taiwan in
2006 with a value of US$159.5 billion.11 Taiwan is a pivotal
site for high-tech industry development in the world, but
increasing demand for high-tech products may increase the
already heavy workload for workers in this industry.
Therefore, the health status of high-tech industry workers
requires immediate attention. Many previous studies
have focused on musculoskeletal discomfort,12 workplace
stress,13 skin disease,14 and lumbar pain,15 among other
issues, but there is a relative paucity of data pertaining to
metabolic abnormalities in the workplace. Most impor-
tantly, the medical expenses related to MS are considerable
and thus cannot be overlooked. Goetzel et al.16 found that
obesity poses a burden of US$644 per worker on companies,
due to medical expenses and loss of productivity. Moreover,
this cost rises to US$3,719 with the occurrence of MS,17
which may have a major impact on the fiscal performance of
the company. Therefore, our study aimed to understand the
prevalence of MS and related factors in high-tech industry
workers, which should facilitate the development of
strategies for promoting appropriate workplace health.
METHODS
Research design and participants
This study was cross-sectional. The subjects were workers
from a company in the integrated circuit industry; the
company contracted a hospital in Taiwan for health
examination services in 2008. A total of 4,666 workers
providing informed consent were included in this study,
and the study was reviewed and approved by the
Institutional Review Board of the target hospital.
Data characteristics and diagnostic criteria
Analytical data were obtained from the health examina-
tion database. These data included gender, age, height, body
weight, blood pressure, waist circumference, and blood
biochemistry markers (i.e., white blood cell count (WBC),
hemoglobin concentration, fasting blood glucose levels,
high-density lipoprotein cholesterol (HDL-C), triglycerides,
uric acid (UA), creatinine, aspartate aminotransferase (AST),
and alanine aminotransferase (ALT)). The body mass index
(BMI) was calculated by dividing weight (in kg) by height
(in m2). Systolic and diastolic blood pressures were
measured using an automatic sphygmomanometer
(UDEX-IIa, UEDA Corp., Tokyo, Japan) and recorded in
the seated position after participants had rested for at least
5 min. Waist circumference was measured with a heavy-
duty inelastic plastic fiber tape measure to the nearest
0.5 cm, while the subject stood balanced on both feet with
the feet touching each other and both arms hanging freely.
Hemoglobin concentration, ALT, AST, triglycerides, fasting
blood glucose, UA, WBC, and HDL-C were evaluated by
automatic bio-assays (Olympus AU-640, Tokyo, Japan).
MS was defined as the presence of three or more of the
following five criteria proposed by the Taiwan National
Health Department:18 (1) fasting blood glucose $100 mg/dl
or self-reported diabetes mellitus; (2) blood pressure $130/
85 mmHg or self-reported hypertension; (3) HDL-C choles-
terol ,40 mg/dl in men or ,50 mg/dl in women; (4)
triglycerides $150 mg/dl; and (5) waist circumference
$90 cm in men or $80 cm in women.
Statistical analysis
Descriptive and inferential analyses were conducted in
accordance with the study’s aims and the nature of the
variables. For descriptive analysis, subjects were grouped
according to the presence of MS. Differences in various
factors between groups are expressed with averages,
standard deviations (SDs), and percentages. Besides gender,
which is shown as a percentage, other variables with
continuous distributions are expressed as averages with
SD. For inferential analysis, t-tests and chi-square tests were
used to explore the relationship between analytical variables
and MS. Multiple logistic regression analysis with the
simultaneous entry method was further used to determine
risk factors and their adjusted odds ratios (AORs). All
analyses were conducted with Statistical Package for Social
Sciences (SPSS) version 15.0 software (SPSS, Inc., Chicago,
IL), and p,0.05 was considered significant.
RESULTS
The 4,666 high-tech industry workers enrolled in this
study included 2,344 men and 2,322 women. Among
subjects, the overall prevalence of MS was 8.2% (382/
4,666) with 14.0% (328/2,344) in men and 2.3% (54/2,322) in
women, revealing a higher MS prevalence in men (p,0.01).
Based on the 2007 population census published by the
Department of Health,19 the age-standardized prevalence
was 5.9%, which was also higher in men than in women
(10.1% vs. 1.7%, p,0.01). Additionally, men also showed
higher BMIs, WBCs, liver enzyme levels, creatinine, UA,
and hemoglobin, as compared to women (p,0.01). Subjects
with MS averaged 33.5 years in age, as opposed to 30.2 years
for those without MS. On average, workers with MS had
significantly higher BMIs and abnormal blood samples, as
compared to those without MS (Table 1).
Our analysis also showed that the most common
metabolic abnormalities among men and women with MS
was higher waist circumference, which was followed by
irregular blood pressure and hypertriglyceridemia; these
disorders had prevalences of 82.0%, 81.4%, and 73.2% in
males and 98.2%, 88.9%, and 64.8% in females, respectively
(Table 2).
Multivariate analysis revealed that men had an AOR of
3.94 (95% confidence interval (CI) = 2.2926.78) for devel-
oping MS, as compared to women. A one-year increase in
age was associated with a 6% (95% CI= 1.04-1.09) increase in
the risk of MS. An increase in BMI of one raised the AOR for
MS by 2% (95% CI= 1.0121.02). Regarding blood biochem-
istry markers, an increase of one unit of ALT increased the
AOR for MS by 30% (95% CI= 1.2621.35). An increase of
one unit of UA or WBC was associated with an increase of
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14% (95% CI= 1.0321.27) and 12% (95% CI= 1.0421.19),
respectively, in the risk of being diagnosed with MS
(Table 3).
DISCUSSION
The overall MS prevalence was 8.2% (14.0% in men and
2.3% in women). Because the average age of the subjects,
who ranged in age from 31 to 40 years, was younger than in
most other epidemiological studies, it is difficult to directly
compare our results with MS prevalence reported else-
where. However, as compared to the prevalence in similarly
aged men and women (10.1%225.8% and 2.1%219.7%,
respectively20-22), the MS prevalence among high-tech
industry workers was lower than in the general population.
This difference may be attributed to the healthy worker
effect: these workers not only must demonstrate a better-
than-average health status to qualify for work but also are
screened by health examinations before being allowed to
enter the high-tech industry.
We found that the most common manifestations of MS in
both men and women were high waist circumference
followed by high blood pressure and hypertriglyceridemia.
However, Pan23 found that blood pressure, triglyceride, and
HDL-C disorders were the most common metabolic
abnormalities among male and female adults in Taiwan.
Another study of 1,562 Taiwanese teenagers indicated that
triglycerides, HDL-C, and waist circumference were the
most common abnormal indicators in male adolescents, as
compared to HDL-C, blood pressure, and waist circumfer-
ence in female adolescents.24 Findings based on the same
ethnic group, therefore, may vary due to age discrepancies
with respect to the leading types of metabolic abnormalities
(one third of Pan’s subjects were aged 45 years or above).
Despite several studies showing a significant correlation
between age and predisposition for MS,21-22 further research
is needed to elucidate whether the leading metabolic
abnormalities vary with age.
Men were at a 3.47-fold greater risk of MS than women,
which is in line with previous studies.22 Two reasons may
account for this phenomenon. First, men are less aware of
self-care than women. For instance, not only do fewer
women smoke and drink, but they are more prone to seek
medical counsel or an examination in the event of physical
discomfort. Thus, the risks for chronic diseases, such as
hypertension and diabetes, are usually lower in women
than in men.25 Second, this study was mostly conducted on
younger subjects, and younger women may benefit from
higher estrogen levels, which decrease serum low-density
lipoprotein-cholesterol (LDL-C) and curb coronary throm-
bosis and atherosclerosis by regulating vascular smooth
muscle and endothelial cells.
Our findings also show that age was positively correlated
with the risk of MS, which is in line with previous studies.20-21
It can be inferred that, with age, blood vessels gradually lose
elasticity and gain resistance, slowing blood flow. Moreover,
with poor circulation, fat is prone to accumulate in the
abdomen and release free fatty acids into the serum, leading
to higher insulin resistance, elevated serum triglyceride levels,
increased small dense LDL-C levels, and, consequently, a
greater risk ofMS.26 This study also showed that a higher BMI
was associated with a greater AOR for developing MS, which
confirms a previous report.21 BMI can be used to assess body
Table 1 - Characteristics of study participants.
Variables MS cases (n= 382) Non-MS cases (n= 4284) p-value
Mean (SD) n (%) Mean (SD) n (%)
Gender
Male 328 (13.99) 2016 (86.01) ,0.01
Female 54 (2.33) 2268 (97.67)
Age 33.52 (5.76) 30.17(5.36) ,0.01
BMI 28.50 (3.68) 22.97(3.75) ,0.01
Liver Enzymes
AST (IU/L) 29.84 (20.04) 19.39 (8.39) ,0.01
ALT (IU/L) 49.99 (34.89) 22.29 (18.05) ,0.01
Creatinine (mg/dl) 1.12 (0.17) 0.99 (0.33) ,0.01
UA (mg/dl) 7.10 (1.48) 5.63 (1.45) ,0.01
WBC (103 cells/ml) 7.93 (1.95) 7.13 (1.87) ,0.01
Hemoglobin (g/dl) 15.05 (1.40) 14.00 (1.52) ,0.01
Table 2 - Sex-specific prevalence of individual metabolic
abnormalities among MS cases.
Metabolic abnormality Male (n= 328) Female (n= 54)
% 95% CI % 95% CI
High triglycerides 73.17 68.37–77.97 64.81 52.07–77.55
High fasting glucose 49.09 43.68–54.50 55.56 42.31–68.81
Abdominal obesity 82.01 77.85–86.17 98.15 94.56–101.74
Low HDL–C 39.63 34.34–44.92 0 0
High blood pressure 81.40 77.17–85.61 88.89 80.51–97.27
Table 3 - Factors associated with MS according to multiple
logistic regression analysis.
Variables Crude OR (95% CI) Adjusted OR (95% CI)
Gender
Male 6.83 (5.09–9.12) 3.94 (2.29–6.78)**
Female 1 1
Age 1.11 (1.08–1.12) 1.06 (1.04–1.09)**
BMI 1.04 (1.03–1.04) 1.02 (1.01–1.02)*
Liver enzymes
AST (IU/L) 1.06 (1.05–1.07) 1.00 (0.96–1.01)
ALT (IU/L) 1.36 (1.32–1.39) 1.30 (1.26–1.35)**
Creatinine (mg/dl) 4.62 (2.83–7.58) 0.73 (0.30–1.76)
UA (mg/dl) 1.87 (1.74–2.01) 1.14 (1.03–1.27)**
WBC (103 cells/ml) 1.21 (1.16–1.27) 1.12 (1.04–1.19)**
Hemoglobin (g/dl) 1.71 (1.57–1.86) 1.00 (0.88–1.13)
*p,0.05;
**p,0.01.
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fat content, which serves as an indicator of obesity. In cases of
obesity, adipose cells release free fatty acids and tumor
necrosis factor-a (TNF-a), which blocks phosphatidylinosi-
tide-3-kinase-dependent signal transduction pathways and
reduces glucose uptake in the liver and skeletal muscles.6,27
To compensate, pancreatic b cells are induced to secrete
excessive insulin, leading to hyperglycemia or type II
diabetes.
We discovered that ALT can better assess the risk of MS
than AST, which is in line with both cross-sectional and
cohort studies.28-29 This finding stems from the storage of
ALT in hepatic cells; therefore, ALT is a more effective
marker for detecting pathogenic hepatic fatty changes
caused by obesity, as compared to AST.29 Two reasons
may explain the positive relationship between ALT and the
risk of MS. First, abnormally elevated ALT is often found in
people under tremendous workplace pressure or extreme
fatigue.30 High psychological pressure may activate the
sympathetic system to raise arterial blood pressure and
reduce renal blood flow.31 Consequently, the patient
develops vasculitic reactions and elevated serum UA levels,
increasing the risk of MS. Second, elevated ALT can also
indicate abnormal liver function caused by fatty liver.28
Once a patient has developed fatty liver, fat accumulation
has usually already occurred in the muscle and other
organs, such as the pancreas. As these tissues release free
fatty acids that inhibit the insulin-based regulation of the
uptake and utilization of glucose, metabolic abnormalities
subsequently emerge.27
This study found a positive correlation between WBC and
the risk of MS, which was in line with previous literature
reports.32-33 A higher WBC may be related to bacterial
infection or vasculitis caused by hyperglycemia and
dyslipidemia. In an inflammatory state, vascular endothelial
cells secrete proinflammatory cytokines, such as interleukin-
6 or TNF-a, which can activate and attract massive numbers
of white blood cells to the damaged region within the lumen
of the vessel.33 Following infiltration into the tunica media,
white blood cells absorb oxidized LDL-C and become foam
cells, which may greatly increase the risk of thromboembo-
lism. Additionally, Rho kinase secreted by white blood cells
can serve as another potential pathogenic mechanism. Liu
et al.32 have found that Rho kinase can block insulin
signaling by stimulating the phosphorylation of insulin
receptor substrate-1. This action prevents the translocation
of glucose to the cell membrane by glucose transporter 4,
thereby leading to insulin resistance.
Our study revealed that workers with MS have a higher
risk of elevated UA, which is in accordance with a previous
report.34 The mechanism involved may be related to the
ability of high levels of UA to inhibit the production of nitric
oxide (NO) by endothelial cells. NO can serve as an
inhibitor of thrombosis and inflammatory reactions, further
preventing the growth and transfer of vascular smooth
muscle cells.35 As for hemoglobin levels, we discovered that
hemoglobin was of borderline significance. Because the
specific biological mechanisms by which hemoglobin levels
increase the risk of MS remain unclear, further study is
needed to clarify the effect of hemoglobin levels on MS,
especially among diverse participants.
The results from this study should be interpreted with the
following limitations in mind. First, subjects were drawn
from a single company in southern Taiwan, and, therefore,
the inferences drawn from the results are not completely
generalizable. More diverse samples collected by a nation-
wide survey or random sampling should be considered in
future research. Second, as a cross-sectional study, we cannot
infer causality from our findings. A longitudinal study design
is needed to investigate any causal relationships among the
factors included in this study. Third, data on potential factors,
such as smoking, alcohol, education, exercise habits, family
history, and worksite pressure were not collected in this
study; lack of information about these factors may have
caused some inferential error. Future studies are needed to
understand the impact of the abovementioned confounding
variables onMS. Moreover, issues related to the medical costs
induced byMS also warrant further evaluation. Despite these
methodological concerns, to our knowledge, this was the first
evidence-based study to estimate the prevalence of MS in
Taiwanese high-tech industry workers. It also involved an
analysis of corresponding health check-up data, which can be
useful in assessing the risk factors for MS because the data
were obtained from standardized laboratory tests.
CONCLUSION
This study explored the prevalence of MS and related
factors among high-tech industry workers. We found that
factors contributing to a high risk of MS included being
male and older, as well as having a higher BMI, increased
ALT, elevated UA, and higher WBC. If our study is
replicated in other occupational settings, the results may
have significant economic and public-health implications
for other shift-work occupational groups, such as the
military, medical service personnel, and police officers.
We believe that our findings support the need to improve
workplace health promotion in the high-tech industry. For
example, appropriate on-site diet and exercise programs
aimed at high-tech industry workers should be implemen-
ted. In addition, occupational managers should actively
offer in-service education concerning MS prevention to
workers and monitor their physical and mental health,
especially in high-risk cases. In summary, the identification
of at-risk workers and disease management programs
addressing MS-related factors are of great importance in
employer-based interventions.
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